Search

Your search keyword '"Martone, Robert"' showing total 158 results

Search Constraints

Start Over You searched for: Author "Martone, Robert" Remove constraint Author: "Martone, Robert"
158 results on '"Martone, Robert"'

Search Results

1. A Cross-sectional Study of Plasma Aβ42/40 Ratio, pTau217, pTau181, GFAP and Nf-L in an Alzheimer’s Disease Clinical Cohort Characterized by Amyloid PET Imaging (P7-9.007)

5. Prejudgment call

6. CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab

7. Dementia Can Unleash Creativity.

8. CSF biomarker variability in the Alzheimer's Association quality control program

9. Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.

12. Enhanced Clearance of Aβ in Brain by Sustaining the Plasmin Proteolysis Cascade

13. Clinical performance of the beta‐amyloid 1‐42/1‐40 ratio determined from automated Lumipulse G1200 cerebrospinal fluid Abeta1‐42 and Abeta1‐40 assays, assessed by concordance with PET imaging status

17. Synthesis and structure–activity relationship of a novel series of heterocyclic sulfonamide γ-secretase inhibitors

20. Reference measurement procedures for Alzheimerʼs disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42

21. Creating Our Sense of Self.

23. The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimerʼs disease

25. How Our Brain Preserves Our Sense of Self.

26. Scientists Demonstrate Direct Brain-to-Brain Communication in Humans.

28. The Fat Woodworker

30. The soul of consciousness: a review of Soul Dust: The Magic of Consciousness

31. When Our Gaze Is a Physical Force.

33. ( S) -N-(5-Chlorothiophene-2-sulfonyl)-β,β-diethylalaninol a Notch-1-sparing γ-secretase inhibitor

34. Discovery of a novel series of Notch-sparing γ-secretase inhibitors

35. Comparative analytical performance of multiple plasma amyloid‐beta assays and their relationship to amyloid PET.

37. Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer's Disease

38. O3-06-07: GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease

39. Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease

40. P3‐101: GSI‐953, a potent and selective gamma‐secretase inhibitor, modulates Abeta peptides in mice and humans: Translating the PK/PD biomarker relationships in different biological compartments between rodent and human

41. P2-302: GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease

42. P2-337: Characterization of the affinity of GSI-953 for binding to gamma-secretase and comparison to benchmark gamma-secretase inhibitors

44. P4-244: Discovery of a novel series of notch-sparing γ-secretase inhibitors

46. Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease

50. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.

Catalog

Books, media, physical & digital resources